Soleno therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4)

Redwood city, calif., june 24, 2024 (globe newswire) -- soleno therapeutics, inc. (“soleno”) (nasdaq: slno), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced, as required by nasdaq stock market rules, the grant of inducement awards to eight new employees.
NDAQ Ratings Summary
NDAQ Quant Ranking